Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sleep Disorders

Free Subscription Articles published in J Neurol Retrieve available abstracts of 40 articles: HTML format

Single Articles

May 2022
1. WANG XT, Yu H, Liu FT, Zhang C, et al
   Associations of sleep disorders with cerebrospinal fluid alpha-synuclein in prodromal and early Parkinson's disease.
   J Neurol. 2022;269:2469-2478.
   PubMed     Abstract available
   
   
   
2. ADAM O, Azher S, Valachovic E, Hahn A, et al
   Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents.
   J Neurol. 2022;269:2430-2439.
   PubMed     Abstract available
   
   
   April 2022
3. YIANGOU A, Mitchell JL, Nicholls M, Chong YJ, et al
   Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT).
   J Neurol. 2022;269:1945-1956.
   PubMed     Abstract available
   
   
   March 2022
4. OLTRA J, Segura B, Uribe C, Monte-Rubio GC, et al
   Sex differences in brain atrophy and cognitive impairment in Parkinson's disease patients with and without probable rapid eye movement sleep behavior disorder.
   J Neurol. 2022;269:1591-1599.
   PubMed     Abstract available
   
   
   
5. MONTANARO E, Romagnolo A, Fabbri M, Artusi CA, et al
   Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson's disease.
   J Neurol. 2022;269:1538-1545.
   PubMed     Abstract available
   
   
   February 2022
6. KOCH J, Willemsen K, Dogan I, Rolke R, et al
   Quantitative sensory testing and norepinephrine levels in REM sleep behaviour disorder - a clue to early peripheral autonomic and sensory dysfunction?
   J Neurol. 2022;269:923-932.
   PubMed     Abstract available
   
   
   January 2022
7. FATEMEH G, Sajjad M, Niloufar R, Neda S, et al
   Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials.
   J Neurol. 2022;269:205-216.
   PubMed     Abstract available
   
   
   
8. GILAT M, Marshall NS, Testelmans D, Buyse B, et al
   A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials.
   J Neurol. 2022;269:125-148.
   PubMed     Abstract available
   
   
   November 2021
9. ZHANG G, Zhang L, Xia K, Zhuang Z, et al
   Daytime sleepiness might increase the risk of ALS: a 2-sample Mendelian randomization study.
   J Neurol. 2021;268:4332-4339.
   PubMed     Abstract available
   
   
   October 2021
10. TITOVA OE, Yuan S, Baron JA, Lindberg E, et al
    Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis.
    J Neurol. 2021 Oct 1. pii: 10.1007/s00415-021-10824.
    PubMed     Abstract available
    
    
    September 2021
11. CORDANI R, Veneruso M, Napoli F, Milanaccio C, et al
    Sleep disturbances in craniopharyngioma: a challenging diagnosis.
    J Neurol. 2021 Sep 14. pii: 10.1007/s00415-021-10794.
    PubMed     Abstract available
    
    
    
12. MARQUES A, Roquet D, Matar E, Taylor NL, et al
    Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.
    J Neurol. 2021;268:3371-3380.
    PubMed     Abstract available
    
    
    August 2021
13. GUO Y, Liu FT, Hou XH, Li JQ, et al
    Predictors of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies.
    J Neurol. 2021;268:2713-2722.
    PubMed     Abstract available
    
    
    July 2021
14. FIELDS T, Schoser B, Oertel W, Strupp M, et al
    Acetyl-DL-leucine improves restless legs syndrome: a case report.
    J Neurol. 2021;268:2595-2596.
    PubMed    
    
    
    
15. SCHAEFFER E, Vaterrodt T, Zaunbrecher L, Liepelt-Scarfone I, et al
    Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
    J Neurol. 2021;268:2506-2514.
    PubMed     Abstract available
    
    
    June 2021
16. SIMONET C, Schrag A, Lees AJ, Noyce AJ, et al
    The motor prodromes of parkinson's disease: from bedside observation to large-scale application.
    J Neurol. 2021;268:2099-2108.
    PubMed     Abstract available
    
    
    April 2021
17. JIMENEZ-JIMENEZ FJ, Amo G, Alonso-Navarro H, Calleja M, et al
    Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome.
    J Neurol. 2021;268:1461-1472.
    PubMed     Abstract available
    
    
    
18. SUZUKI K, Suzuki S, Haruyama Y, Okamura M, et al
    Central sensitization in migraine is related to restless legs syndrome.
    J Neurol. 2021;268:1395-1401.
    PubMed     Abstract available
    
    
    March 2021
19. IRANZO A, Marrero-Gonzalez P, Serradell M, Gaig C, et al
    Significance of hyposmia in isolated REM sleep behavior disorder.
    J Neurol. 2021;268:963-966.
    PubMed     Abstract available
    
    
    February 2021
20. CHEN CY, Chen CL, Yu CC
    Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study.
    J Neurol. 2021 Feb 24. pii: 10.1007/s00415-021-10480.
    PubMed     Abstract available
    
    
    January 2021
21. MARELLI S, Castelnuovo A, Somma A, Castronovo V, et al
    Impact of COVID-19 lockdown on sleep quality in university students and administration staff.
    J Neurol. 2021;268:8-15.
    PubMed     Abstract available
    
    
    
22. XU Z, Anderson KN, Saffari SE, Lawson RA, et al
    Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study.
    J Neurol. 2021;268:312-320.
    PubMed     Abstract available
    
    
    
23. ANDELIC N, Roe C, Brunborg C, Zeldovich M, et al
    Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study.
    J Neurol. 2021;268:61-73.
    PubMed     Abstract available
    
    
    June 2020
24. DAFSARI HS, Ray-Chaudhuri K, Ashkan K, Sachse L, et al
    Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    J Neurol. 2020;267:1830-1841.
    PubMed     Abstract available
    
    
    May 2020
25. HATTORI M, Tsuboi T, Yokoi K, Tanaka Y, et al
    Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study.
    J Neurol. 2020;267:1516-1526.
    PubMed     Abstract available
    
    
    April 2020
26. ELFIL M, Ahmed N, Alapati A, Bahekar R, et al
    Suicidal risk and demoralization in Parkinson disease.
    J Neurol. 2020;267:966-974.
    PubMed     Abstract available
    
    
    February 2020
27. RATTAY TW, Boldt A, Volker M, Wiethoff S, et al
    Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).
    J Neurol. 2020;267:369-379.
    PubMed     Abstract available
    
    
    
28. MASSEY TH, Robertson NP
    Restless legs syndrome: causes and consequences.
    J Neurol. 2020;267:575-577.
    PubMed    
    
    
    
29. LABERGE L, Gallais B, Auclair J, Dauvilliers Y, et al
    Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
    J Neurol. 2020;267:461-468.
    PubMed     Abstract available
    
    
    
30. MATAR E, Ehgoetz Martens KA, Halliday GM, Lewis SJG, et al
    Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology.
    J Neurol. 2020;267:380-389.
    PubMed     Abstract available
    
    
    
31. LU HT, Shen QY, Zhao QZ, Huang HY, et al
    Association between REM sleep behavior disorder and impulsive-compulsive behaviors in Parkinson's disease: a systematic review and meta-analysis of observational studies.
    J Neurol. 2020;267:331-340.
    PubMed     Abstract available
    
    
    January 2020
32. KEIR LHM, Breen DP
    New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease.
    J Neurol. 2020;267:288-294.
    PubMed     Abstract available
    
    
    December 2019
33. GAETA AM, Benitez ID, Jorge C, Torres G, et al
    Prevalence of obstructive sleep apnea in Alzheimer's disease patients.
    J Neurol. 2019 Dec 12. pii: 10.1007/s00415-019-09668.
    PubMed     Abstract available
    
    
    November 2019
34. FERRAZZANO G, Berardelli I, Conte A, Baione V, et al
    Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications.
    J Neurol. 2019;266:2780-2785.
    PubMed     Abstract available
    
    
    September 2019
35. BARGIOTAS P, Dietmann A, Haynes AG, Kallweit U, et al
    The Swiss Narcolepsy Scale (SNS) and its short form (sSNS) for the discrimination of narcolepsy in patients with hypersomnolence: a cohort study based on the Bern Sleep-Wake Database.
    J Neurol. 2019;266:2137-2143.
    PubMed     Abstract available
    
    
    July 2019
36. READING PJ
    Update on narcolepsy.
    J Neurol. 2019;266:1809-1815.
    PubMed     Abstract available
    
    
    June 2019
37. ZAREMBA S, Albus L, Schuss P, Vatter H, et al
    Increased risk for subarachnoid hemorrhage in patients with sleep apnea.
    J Neurol. 2019;266:1351-1357.
    PubMed     Abstract available
    
    
    
38. ALDAZ T, Nigro P, Sanchez-Gomez A, Painous C, et al
    Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.
    J Neurol. 2019;266:1340-1350.
    PubMed     Abstract available
    
    
    May 2019
39. ALEKSEEVA TM, Kreis OA, Gavrilov YV, Valko PO, et al
    Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis.
    J Neurol. 2019 May 21. pii: 10.1007/s00415-019-09374.
    PubMed     Abstract available
    
    
    April 2019
40. OKUDA S, Tetsuka J, Takahashi K, Toda Y, et al
    Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.
    J Neurol. 2019 Apr 9. pii: 10.1007/s00415-019-09286.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: